Michael P. La Quaglia, MD, FACS, FRCS
Pediatric Surgical Oncologist
Joseph H. Burchenal Chair in Pediatrics
Pediatric Surgical Oncology; Wilms' Tumor; Neuroblastoma; Sarcomas; Neuroectodermal Tumors; Thyroid Cancer; Genitourinary Malignancies; Ovarian and Testicular Tumors; Kidney Cancers; Hepatic Tumors; Congenital Anomalies
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. La Quaglia accepts the following list of insurance providers. Select your insurance provider to see more details.
Memorial Sloan Kettering is an in-network provider with Aetna HMO, POS, and PPO plans. Aetna does not include us in any of the plans you can purchase through the insurance exchanges or through Medicare. Please ask your insurance if you need a one-time referral. MSK has an agreement with the Aetna Transplant Program for all Aetna's commercial products.
Memorial Sloan Kettering is a designated Blue Distinction Center for bone marrow transplant and CAR-T.
We understand that there may be many complexities involved with insurance coverage purchased through the health exchange network of the Affordable Care Act. We’re here to help. If you have questions about how your care will be covered by an insurance provider, or need help navigating a change in coverage, please call us at 646-227-3378; if you are not a resident of New York, you can call us at 866-248-1274. Our team is here to listen to your concerns and assist you in any way we can. We want our care to be as accessible and affordable for as many people as possible.
Memorial Sloan Kettering is an in-network provider with CIGNA's HMO, POS, and PPO plans. CIGNA does not include us in any of the plans you can buy through the insurance exchanges.
- If you are a New York State resident: Please ask your insurance if you need a one-time referral.
- If you live outside of New York State: Please ask your insurance if you have in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with EmblemHealth’s PPO, EPO, POS, HMO plans. EmblemHealth includes GHI, HIP, Vytra, and ConnecticCare (in NYS Only). You must bring a referral from your Emblem primary care doctor to your first appointment. In-network participation exceptions include:
- Emblem’s HIP Commercial Millennium, Select Care and Enhanced Care Prime networks is not in-network with Memorial Sloan Kettering.
- Please call Emblem to confirm if your specific plan is in-network.
For information regarding Memorial Sloan Kettering’s participation with Emblem’s Medicare Advantage Plans, please refer to the Medicare & Medicaid page
Memorial Sloan Kettering is an in-network provider with Empire Blue Cross Blue Shield (Wellpoint) of New York Indemnity, HMO, EPO, PPO, POS and Medicare Advantage plans, with the following exceptions:
- Empire Blue Cross Blue Shield does not include us in any of the plans you can buy through the insurance exchanges.
- Please call Empire BCBS to confirm if your specific plan is in-network with Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with HealthFirst’s commercial products; these commercial products are not purchased on the insurance exchanges.
Memorial Sloan Kettering is an in-network provider with HealthSmart’s Accel, HSPC, and HPO networks.
For our NJ locations, Memorial Sloan Kettering is an in-network provider with most Horizon Blue Cross Blue Shield of New Jersey plans for individuals, families, and small businesses. Horizon members with Blue Card Access (there would be a suitcase logo on the front of the card) may have access to our NY locations. Please call Horizon to confirm if your plan is in-network in NY.
Memorial Sloan Kettering is a designated Center of Excellence by Humana.
Memorial Sloan Kettering is a designated Center of Excellence by Interlink Health Services.
Memorial Sloan Kettering is a designated Center of Excellence by Lifetrac.
Memorial Sloan Kettering is an in-network provider for all MagnaCare health plans except those products you can buy through the insurance exchanges.
For information about Medicare and Medicaid, please visit this page
Memorial Sloan Kettering is an in-network provider with some Multiplan/Beech Street/PHCS plans. Contact your insurance carrier to find out if your plan provides in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is a designated Center of Excellence by Multiplan.
If you are covered by more than one insurance plan, you will want to determine your benefits from both plans. First, you need to determine which one is your primary insurance provider by contacting your employee benefits office or your insurance carriers. After you find out which is your primary insurance provider, you should then contact your insurance carrier to determine if you have access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with some MVP plans. Contact your insurance carrier to find out if your plan provides in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider for New York State employees who have enrolled in UnitedHealthcare's Cancer Resource Services. If you have the Empire Plan, you should call Cancer Resources Services at 866-936-6002 to verify and enroll in this coverage.
Memorial Sloan Kettering is in-network with Oscar’s Circle Plus Network, a part of its Small Group Broad line that is offered only to select small business groups. Oscar does not include Memorial Sloan Kettering as an in-network provider for any of its individual plans. Please confirm eligibility with your insurance carrier.
Most Blue Cross Blue Shield plans include Memorial Sloan Kettering as an in-network provider. Contact your insurance company to confirm if Memorial Sloan Kettering is in-network.
We have agreements with several insurance companies that may provide additional coverage for cancer patients. These benefit programs include:
- AXA Assistance USA
- Beech Street
- Integrated Health Plans
- National Health Administrators
- National Preferred Provider Network
- UnitedHealthcare's Cancer Resource Services
- United Resource Network
- Veterans Choice Program
Memorial Sloan Kettering is an in-network provider with Oxford’s Freedom and Liberty plans as well as the Metro Plan (which is only offered to small business groups and no longer offered as individual plans). Please confirm with your insurance if you need a one-time referral. Note: Oxford’s Medicare Managed Care plan — Secure Horizon — does not include Memorial Sloan Kettering as an in-network provider. Oxford does not include us in any of the plans you can buy through the insurance exchanges.
Memorial Sloan Kettering is an in-network provider with the World Trade Center Health Program.
Memorial Sloan Kettering is an in-network provider with QualCare's PPO and HMO/POS network.
Memorial Sloan Kettering is a designated Center of Excellence by Specialty Care Management.
Hospital and physician services may be covered by TRICARE. Please call your TRICARE plan to confirm coverage at Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with UnitedHealthCare's HMO, POS, and PPO plans. Please confirm with your insurance if a one-time referral is needed.
UnitedHealthCare's Medicare Managed Care plan does not include Memorial Sloan Kettering as an in-network provider.
United does not include us in any of the plans you can buy through the insurance exchanges.
Memorial Sloan Kettering is a designated Center of Excellence by UnitedHealthcare.
Contact and Location
Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
MD, University of Medicine and Dentistry of New Jersey
General Surgery - Massachusetts General Hospital; Pediatric Surgery - Children's Hospital Medical Center
Cardiothoracic Surgery - Regional Thoracic Centre; Vascular Surgery - Massachusetts General Hospital; Surgery - Harvard Medical School
Surgery; Pediatric Surgery
I am a pediatric surgeon who is committed to the treatment of children and adolescents with cancer, and I am rewarded every day by my experiences with my patients and their families. I take care of children with Wilms’ tumors, neuroblastoma, liver tumors, desmoplastic small round cell tumors, sarcomas, melanomas and thyroid tumors.
I am proud to be part of a team that performs more pediatric cancer surgeries than any other institution in the world; more than 500 procedures each year, in patients as young as newborn to young adults. We have special expertise in performing large, complicated surgeries, with exceptional experience in surgery for neuroblastoma and desmoplastic small round cell tumors as well as complex liver surgery and thyroid surgery.
Whenever possible, my colleagues and I apply minimally invasive surgical approaches, such as thoracoscopy and laparoscopy, to the treatment of childhood cancers. These approaches help speed the recovery of our patients and their return to their normal activities.
In my research, I am collaborating with my colleagues to assess a class of drugs called histone deacetylase inhibitors as anticancer agents. These novel drugs work against cancer by turning off an enzyme the cancers need to grow. I have studied the mechanisms by which cancers metastasize (spread), and I am working with other investigators to study the role of angiogenesis — the development of blood vessels tumors need — in this process. Since metastasis is what ultimately causes patients to succumb to cancer, learning how to halt this process will be enormously beneficial.
I also lead clinical trials, such as one assessing radioimmunotherapy for desmoplastic small round cell tumors. My work supports the banking of tumor tissue, particularly for neuroblastoma and sarcoma — the study of which can benefit future patients with cancer. I also teach and mentor surgical fellows and residents.
Nationally, I serve as Chairperson of the Surgical Committee of the Children’s Oncology Group. I am a member and past chairman of the Pediatric Surgical Association Cancer Committee. I have received the Willet F. Whitmore Award for Clinical Excellence from Memorial Sloan Kettering and am a fellow of the Royal College of Surgeons in Edinburgh. I hold the Joseph H. Burchenal Chair in Pediatrics, which is named for an esteemed pioneer in the treatment of cancer in children. The National Cancer Institute also gave me an award for my work on the Pediatric Physician Data Query (PDQ) information summaries, which provide up-to-date cancer information for healthcare professionals and parents/patients.
My greatest satisfaction, however, comes from working with children. I enjoy my interactions with them tremendously and find them extremely rewarding. I feel immensely grateful to be able to help someone get better, especially when I can do something that others say they cannot. When your child is with me in the operating room, you can be assured that I will treat him or her as my own.
Awards and Honors
- Castle Connolly: New York Magazine Top Doctors (2002-2020)
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Research and Publications
Selected Book Chapters
“Childhood tumors.” La Quaglia MP. In: Greenfield’s Surgery: Scientific Principles and Practice. Mulholland MW, Lillemoe KD, Doherty GM, Maier RV, Upchurch GR Jr, eds. Philadelphia: Lippincott Williams & Wilkins; 2006: 1956-1981.
“Neuroblastoma and other adrenal tumors.” La Quaglia MP, Rutigliano DN. Carachi R, Grosfeld JL, Azmy AF, eds. In: The Surgery of Childhood Tumors. 2nd ed. Heidelberg: Springer-Verlag; 2008: 201-226.
“Peripheral neuroectodermal tumors.” La Quaglia MP. In: Reoperative Pediatric Surgery. Teich S, Caniano DA, eds. Totowa, NJ: Humana Press; 2008:427-434.
“Surgical management of pediatric tumors.” La Quaglia MP. In: Cancer in Children and Adolescents. Carroll W, Finlay J, eds. Boston: Jones and Bartlett Publishers; 2009: 113-122.
“Hepatic tumors in childhood.” Sri Paran T, La Quaglia MP. In: Pediatric Surgery: Diagnosis and Management. Puri P, Hollwarth M, eds. Berlin: Springer-Verlag; 2009: 727-736.
“Wilms’ tumor.” Wolden SL, La Quaglia MP. In: Leibel and Phillips Textbook of Radiation Oncology. 3rd ed. Hoppe RT, Phillips TL, Roach M, eds. Philadelphia: Saunders; 2010: 1203-1214.
“Childhood tumors.” Rich BS, La Quaglia MP. In: Greenfield’s Surgery: Scientific Principles and Practice. 5th ed. Mulholland MW, Lillemoe KD, Doherty GM, Maier RV, Simeone DM, Upchurch GR Jr, eds. Philadelphia: Lippincott Williams & Wilkins; 2010: 1956-1982.
“Hepatic tumors.” Prasad J, La Quaglia MP. In: Newborn Surgery. 3rd ed. Prem Puri, ed. New York: Oxford UP; 2011: In press.
“Neuroblastoma.” Rich BS, La Quaglia MP. In: Pediatric Surgery. 7th ed. Coran AG, Adzick NS, Krummel TM, Laberge JM, Shamberger RC, Caldamone AA, eds. Philadelphia: Saunders; 2012: 441-458.
“Hepatic tumors in childhood.” Rich BS, La Quaglia MP. In: Blumgart’s Surgery of the Liver, Biliary Tract, and Pancreas. 5th ed. Blumgart LH, Jarnagin WR, Belghiti J, et al., eds. Philadelphia: Saunders; 2012: 1328-1343.
Visit PubMed for a full listing of Dr. La Quaglia’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Michael P. La Quaglia discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.